NRC Health Common Stock (NRC) is a publicly traded Healthcare sector company. As of July 28, 2026, NRC trades at $22.37 with a market cap of $479.36M and a P/E ratio of 0.46. NRC moved +5.17% today. Year to date, NRC is +19.02%; over the trailing twelve months it is +60.32%. Its 52-week range spans $9.76 to $23.25. Analyst consensus is buy with an average price target of $23.00. Rallies surfaces NRC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for NRC shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $22.37 |
| Market Cap | $479.36M |
| P/E Ratio | 0.46 |
| EPS | $50.00 |
| Dividend Yield | 0.16% |
| 52-Week High | $23.25 |
| 52-Week Low | $9.76 |
| Volume | 89.40K |
| Avg Volume | 0 |
| Revenue (TTM) | $137.39M |
| Net Income | $11.60M |
| Gross Margin | 61.88% |
1 analysts cover NRC: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $23.00.